Product
Bivalent rLukS-PV / rAT
1 clinical trial
1 indication
Indication
Staphylococcus aureusClinical trial
A Randomized, Multi-Center Trial to Evaluate the Safety & Immunogenicity of Staphylococcus Aureus Toxoids, rAT and rLukS-PV, in Healthy VolunteersStatus: Completed, Estimated PCD: 2011-03-01